Publicação
Tissue structure developer: jellyfish-based collagen as an innovative wound healing treatment - business development & financial structure
| Resumo: | TSD, a novel biotech venture, aims to revolutionise the wound healing market by utilising jellyfish, a new source of collagen. Its product, the CollaPatchTM, harnesses the benefits of jellyfish collagen across social, environmental, and ecological dimensions, offering a superior alternative to bovine- and porcine-based collagen products for wound healing. TSD strives to capture significant market share in the treatment of both acute and chronic wounds by presenting a comprehensive business model, covering the diverse user and customer needs, existing and potential competitors, the optimal path to commercialisation, the required steps in the development roadmap and valuable funding and exit opportunities. |
|---|---|
| Autores principais: | Gartmann, Martin Christoph |
| Assunto: | Entrepreneurship Intrapreneurship Venture capital Innovation Pharmaceutical Biotechnology Biomedical innovation Business strategy Intellectual property Competitive analysis Funding Ulcers Wound healing Chronical wounds Jellyfish |
| Ano: | 2024 |
| País: | Portugal |
| Tipo de documento: | dissertação de mestrado |
| Tipo de acesso: | acesso aberto |
| Instituição associada: | Universidade Nova de Lisboa |
| Idioma: | inglês |
| Origem: | Repositório Institucional da UNL |
| Resumo: | TSD, a novel biotech venture, aims to revolutionise the wound healing market by utilising jellyfish, a new source of collagen. Its product, the CollaPatchTM, harnesses the benefits of jellyfish collagen across social, environmental, and ecological dimensions, offering a superior alternative to bovine- and porcine-based collagen products for wound healing. TSD strives to capture significant market share in the treatment of both acute and chronic wounds by presenting a comprehensive business model, covering the diverse user and customer needs, existing and potential competitors, the optimal path to commercialisation, the required steps in the development roadmap and valuable funding and exit opportunities. |
|---|